Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3699103014 | Lidocaine hydrochloride 10 mg/mL and methylprednisolone acetate 40 mg/mL suspension for injection vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3699104015 | Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Lidocaine hydrochloride | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | This attribute specifies the numerator unit for the concentration strength of a product. | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | Has concentration strength denominator value | en | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | This attribute specifies the denominator unit for the presentation strength of a product. | mL | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Methylprednisolone acetate | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | Is a | Product containing lidocaine and methylprednisolone (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | Has presentation strength denominator value | en | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | Is a | Lidocaine-containing product in parenteral dose form | false | Inferred relationship | Some | ||
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | Has presentation strength numerator value | 40 | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Lidocaine hydrochloride | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | Is a | Product containing methylprednisolone in parenteral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | Has presentation strength denominator value | en | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | This attribute specifies the numerator unit for the presentation strength of a product. | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | Has manufactured dose form | Suspension for injection | false | Inferred relationship | Some | ||
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | Has presentation strength numerator value | ti | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | This attribute specifies the denominator unit for the concentration strength of a product. | mL | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | This attribute specifies the denominator unit for the presentation strength of a product. | mL | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | Has concentration strength numerator value | ti | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | This attribute specifies the numerator unit for the presentation strength of a product. | mg | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | Has concentration strength denominator value | en | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | This attribute specifies the numerator unit for the concentration strength of a product. | mg | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | Count of base of active ingredient | to | false | Inferred relationship | Some | ||
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Methylprednisolone acetate | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | This attribute specifies the denominator unit for the concentration strength of a product. | mL | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | Has concentration strength numerator value | 40 | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial | Has unit of presentation | Vial (unit of presentation) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)
FHIR